Sultan Qaboos University (SQU) has achieved a significant milestone in the commercial production of spirulina, a highly nutritious microalgae increasingly recognized worldwide for its role in food security, health supplements, and sustainable production systems.

Conventional treatments of Alzheimer’s disease, one of the most common forms of dementia, have been largely focused on targeting individual pathological features. However, Alzheimer’s disease is a multifactorial disorder driven by multiple, tightly interconnected processes, rendering single-target therapeutic approaches inherently limited. Addressing this challenge, KAIST researchers propose a new strategy that enables the simultaneous regulation of multiple disease-inducing factors simply by rearranging the structural positions of drug candidate molecules without altering their chemical substituents.

The cGAS‑STING pathway detects cellular DNA to trigger type I interferons and cytokines. This review integrates mechanistic immunology with clinical oncology perspectives, dissecting pathway components, regulatory factors, and therapeutic potential for cancer and diverse diseases, bridging fundamental discoveries to clinical applications.

Osaka Metropolitan University researchers investigated the relationship between Long COVID symptoms and smoking by tobacco product type. The researchers found that certain symptoms correlated with different forms of smoking.

On November 2, 2025, the research group led by Dr. Zeng Ling from Army Medical University systematically elucidated the molecular mechanisms, pathological processes, and latest clinical advances in sepsis-induced endothelial barrier dysfunction from the perspective of vascular endothelial cells. This work provides novel insights for precise intervention in sepsis and septic shock. The findings were published in Research under the title "Sepsis-Induced Endothelial Barrier Dysfunction: Mechanisms, Pathology, and Therapeutic Advances" (Research, 2025, Article ID: 0997, DOI: 10.34133/research.0997).

Researchers from NUS Medicine have uncovered how a high-risk class of genetic vectors can efficiently spread antibiotic resistance within the gut, enabling even highly virulent bacteria to acquire drug resistance under real-world conditions. The findings shed new light on how so-called “superbugs”, bacteria that are both highly virulent and antibiotic-resistant, can emerge and persist, particularly in healthcare settings.